Rhythm Pharmaceuticals Inc header image

Rhythm Pharmaceuticals Inc

RYTM

Equity

ISIN null / Valor 25337263

NASDAQ (2026-07-07)

USD 114.46+2.49%

Rhythm Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Rhythm Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare genetic disorders of obesity, specifically those related to the melanocortin-4 receptor (MC4R) pathway. These disorders are distinct from general obesity and are characterized by early-onset, severe obesity and hyperphagia, a condition marked by an insatiable hunger. The company's primary focus is on addressing these rare MC4R pathway impairments to provide targeted therapeutic solutions for patients suffering from these debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

72.4%1Y

624%3Y

483%5Y

Performance

54.3%1Y

55.3%3Y

74.2%5Y

Volatility

7844 M

Market cap (USD)

998,560

Daily traded volume (Shares)

56.78 / 55.07

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

5.00

Society:

5.00

Nature:

2.00

Adrian Pusz

Switzerland, 20 Apr 2025

Rhythm develops what will always be needed - rare disease therapies

EQUITIES OF THE SAME SECTOR

Asker Healthcare Group AB

Asker Healthcare Group AB Valor: 143378021

Annual Return

-50%0%+50%

Risk level

110

0.67%SEK 83.20

Alkem Laboratories Ltd.

Alkem Laboratories Ltd. Valor: 30689895

Annual Return

-50%0%+50%

Risk level

110

1.20%INR 5,664.75

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB Valor: 2676862

Annual Return

-50%0%+50%

Risk level

110

-0.04%SEK 479.80

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

1.93%GBP 30.52

Spire Healthcare Group PLC

Spire Healthcare Group PLC Valor: 24881418

Annual Return

-50%0%+50%

Risk level

110

0.23%GBP 2.17

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Valor: 332902

Annual Return

-50%0%+50%

Risk level

110

0.49%EUR 43.41

L'Oreal S.A.

L'Oreal S.A. Valor: 502805

Annual Return

-50%0%+50%

Risk level

110

2.74%EUR 388.35

MPH Health Care AG

MPH Health Care AG Valor: 57233620

Annual Return

-50%0%+50%

Risk level

110

0.34%EUR 29.30

The Platform Group AG

The Platform Group AG Valor: 57796644

Annual Return

-50%0%+50%

Risk level

110

-0.67%EUR 0.89

Geratherm Medical AG

Geratherm Medical AG Valor: 1091371

Annual Return

-50%0%+50%

Risk level

110

2.22%EUR 2.76

SIX

FactSet

Clearbit

Logos provided by Clearbit